Polyderm PLLA Poly-l-lactic acid Powder

Polyderm PLLA powder contains Poly-l-lactic acid, it is one of the most well-researched and common polymer for biodegradable medical device volumizing filler. Polyderm PLLA is a collagen stimulator which is used to diminish facial wrinkles by helping to restore the deep, underlying structure of the skin. Results appear gradually over the treatment regime (typically three injections over the course of three to four months) and can last more than two years.

This filler is injected deep into your skin to reinforce the structure of your skin, it will encourage the production of new collagen. It is a FDA approval safe material and proven treatment for facial aging. Polyderm PLLA powder is made for facial volumes and strengthening heavy ptosis tissues, it contains poly-L-lactic acid, which is a biocompatible, biodegradable substance that is gradually and naturally absorbed by the body and commonly found in dissolvable stitches. As a poly-L-lactic acid (PLLA) collagen stimulator, Polyderm PLLA is different from typical dermal fillers such as hyaluronic acid. Poly(L-lactide) is a biodegradable material with good bio-absorbability and bio-compatibility. After degradation in the body, PLLA products are excreted by metabolism and thus has no harmful side effects to the human body. It works with your body within the deep dermis, rather than topically, to help revitalize collagen production and help restore your skin’s inner structure and volume. As the PLLA microparticles are absorbed, they help stimulate collagen production. Rebuilt collagen strands begin gradually helping to restore facial volume4 and the look of fullness to wrinkles and folds.

Expected Effect:

Tissue Compaction

Improving skin tone

Facial wrinkle removal

Lifting effect

POLYCAPROLACTONE, OBSORBABLE, NON-ALLERGENIC, NON-TOXIC, NON-PYROGENIC SURGICAL SUTURE.

FULLY BIODIGRADATE FROM 6 MONTHS TO 3 YEARS (DEPENDING ON THE THICKNESS OF THE MATERIAL) WITH THE FORMATION OF THE CONNECTIVE TISSUES AROUND THE SURFACE OF THE SUTURE.

IN THE BODY, PCL BIODEGRADATION OCCURS MAINLY IN THE HYDROLYTIC PROCESS WITH THE FORMATION OF HYDROXYCAPROIC ACID MONOMERS, WITH THE SUBSEQUENT BIODEGRADATION IN WATER AND CARBON DIOXIDE.